Stereotactic Body Therapy Radiation for the Treatment of Early Stage Non Small Cell Lung Cancer

Judith Walsh, MD, MPH

Disclosures

CTAF 

In This Article

Abstract and Introduction

Introduction

The California Technology Assessment Forum (CTAF) was requested to review the scientific evidence for the use of Stereotactic Body Radiation Therapy (SBRT) for the treatment of early stage non small cell lung cancer (NSCLC) in medically inoperable patients. Given that the major treatment goal for non small cell lung cancer is to obtain local control, is SBRT a viable therapeutic option for patients who are medically inoperable? Secondarily, given its potentially less invasive approach, is it a viable option for patients who are potentially operable as an alternative to surgery?

CTAF evaluated this topic in June, 2008, but has been asked to readdress the topic in light of additional published evidence. Most of the available evidence focuses on the use of radiosurgery for treatment of medically inoperable patients who have few treatment options. However, SBRT is also being evaluated for patients who have operable cancers and its use in this patient population will be addressed as well.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....